Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
Clinical trial NCT00002186 · COMPLETED
Trial details
- NCT number
- NCT00002186
- Sponsor
- Shaman Pharmaceuticals
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.